newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights

- On Track to Report Initial Results from Phase 2 pheNIX Gene Therapy Trial for Adults with PKU in 2021- - Plans to Initiate First-Ever Gene Editing Trial for PKU with HMI-103 This Year - - Expects to Commence Clinical Trial with HMI-203 In Vivo Ge